AzTrials
AzTrials

Dental Caries (Diagnosis)NILTNCT07041164

Diagnostic Performance and Children's Acceptance of Near-Infrared Light Transillumination and Bitewing Radiographs for Detecting Proximal Cavitation in Primary Molars of Patients Aged 4 to 10 Years

An observational study of Dental Caries (Diagnosis) and Diagnostic Imaging, run by Sawanya Prutthithaworn at 2 sites in Thailand.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to compare the diagnostic performance of three detection methods for approximal carious lesions in primary molars among pediatric patients aged 4-10 years. The study focuses on children in three age groups: 4-6 years, 6-8 years, and 8-10 years. Read more about this study

Who is it for?
Ages 4 to 10 yearsHealthy volunteers can take part
What is being tested?
Bitewing radiograph and Near-infrared light transillumination
How many people
174 participants
Where
2 sitesThailand
Study dates
1 Aug 2025to 30 Apr 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Pediatric dental clinic

Who may be able to join

  • Healthy Children aged 4-10 years
  • Low risk for periodontal disease
  • At least one quadrant contains fully erupted, well-aligned adjacent primary molars that are free of restorations, exhibit no clinically visible cavitated caries, demonstrate tooth mobility of grade 2 or less, show no developmental dental anomalies
  • Bitewing radiographs show at least one radiolucent lesion in the proximal surface of a primary molar classified as RA2 or RA3 according to the ICDAS II radiographic criteria

Who cannot join

  • Root resorption exceeding two-thirds of the root length
  • Demonstrate Frankl's behavior rating scale of 1 during either near-infrared light transillumination examination or tooth separation

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Sawanya Prutthithaworn, Ph.D. (Dental biomaterials) contact

+6622007821 ext. 25

sawanya.pru@mahidol.ac.th

Thailand2 sites, 2 recruiting
  • Dental Hospital, Faculty of Dentistry, Mahidol University (Phayathai Campus)

    Bangkok, 10400

    Yuwadee Asavanund, Cert. in Pediatric Dentistry, +6622007821, yawadee.asv@mahidol.ac.th

    Apiwan Smutkeeree, M.Clin.Dent, apiwan.dan@mahidol.ac.th

    Not yet recruiting
  • Dental Hospital, Faculty of Dentistry, Mahidol University (Phayathai Campus)

    Bangkok, 10400

    Yuwadee Asavanund, Cert. in Pediatric Dentistry, +6622007821, yawadee.asv@mahidol.ac.th

    Apiwan Smutkeeree, M.Clin.Dent, apiwan.dan@mahidol.ac.th

    Recruiting

Other trials in Thailand

About this study

The goal of this observational study is to compare the diagnostic performance of three detection methods for approximal carious lesions in primary molars among pediatric patients aged 4-10 years. The study focuses on children in three age groups: 4-6 years, 6-8 years, and 8-10 years. The main questions it aims to answer are:

  • Are the sensitivity, specificity, accuracy, and area under the curve (AUC) different across the three diagnostic techniques (bitewing radiography, near-infrared light transillumination, and their combination)?
  • Are these diagnostic parameters influenced by patient age?
  • Which technique yields the highest level of patient acceptance?
Read more

Researchers will compare the three diagnostic approaches to determine whether age influences diagnostic performance and patient acceptance.

Participants will:

  • Be examined using bitewing radiography and near-infrared light transillumination
  • Undergo tooth separation for 7 days using orthodontic elastic separators
  • Receive clinical examination of the target approximal surface
  • Be asked to rate their experience using the Simplified Facial Pain Scale (S-FPS)
Read the detailed description
  • 58 carious lesions classified as RA2 and RA3 according to the ICDAS II criteria from three groups of 4-6 years, 6-8 years, and 8-10 years pediatric patients will be examined by near-infrared light transillumination
  • The patient acceptance towards bitewing radiograph and near-infrared light transillumination will be evulated by Simplified Facial Pain Scale (S-FPS)
  • Diagnostic performance will be assessed by calculating sensitivity, specificity, accuracy, and the area under the curve (AUC)
  • The diagnostic efficacy of the caries detection methods will be analyzed using repeated measures ANOVA, and patient acceptance will be assessed using the Chi-square test, with statistical significance set at p < 0.05 and a 95% confidence level.
Being tested
Bitewing radiograph, Near-infrared light transillumination
Keywords
proximal caries, primary molars, Pediatric Patients, Bitewing Radiography, Near-Infrared Light Transillumination, DIAGNOcam, clinical cavitation, children acceptance, Diagnostic accuracy
Medical subject headings
Dental Caries, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bitewing radiographDiagnostic test

    Digital radiograph, proximal caries, initial caries

  • Near-infrared light transilluminationDiagnostic test

    DIAGNOcam, proximal caries, initial caries

Study groups in NCT07041164
Study groupRoleWhat they receive
4-6 years oldNot described
Receives: Diagnostic Test: Bitewing radiograph; Diagnostic Test: Near-infrared light transillumination
6-8 years oldNot described
Receives: Diagnostic Test: Bitewing radiograph; Diagnostic Test: Near-infrared light transillumination
8-10 years oldNot described
Receives: Diagnostic Test: Bitewing radiograph; Diagnostic Test: Near-infrared light transillumination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnosis performance

    The diagnostic performance will be described by sensitivity, specificity, accuracy, and the Area Under the Curve (AUC), with values ranging from 0 to 1 for each parameter.

    • For sensitivity, zero is equivalent to no true positives detected, and 1 indicates all true positives detected
    • For specificity, zero is equivalent to no true negatives detected, and 1 indicates all true negatives detected
    • For accuracy, zero is equivalent to all cases misclassified, and 1 indicates all cases correctly classified
    • For AUC, zero is equivalent to a perfectly incorrect classification, and 1 indicates a perfectly correct classification

    Measured: From enrollment to clinical examination on day 7th

  2. Age-influenced on diagnostic performance

    The diagnostic performance for each age group will be described by sensitivity, specificity, accuracy, and the Area Under the Curve (AUC), with values ranging from 0 to 1 for each parameter.

    • For sensitivity, zero is equivalent to no true positives detected, and 1 indicates all true positives detected.
    • For specificity, zero is equivalent to no true negatives detected, and 1 indicates all true negatives detected.
    • For accuracy, zero is equivalent to all cases misclassified, and 1 indicates all cases correctly classified.
    • For AUC, zero is equivalent to a perfectly incorrect classification, and 1 indicates a perfectly correct classification.

    Measured: From enrollment to clinical examination at day 7th

Secondary outcomes (1)
  1. Children's acceptance

    Children's acceptance will be evaluated using the Simplified Facial Pain Scale (S-FPS), which ranges from 0 to 10. The minimum value is 0, representing "no pain", and the maximum value is 10, representing "severe pain".

    Measured: From enrollment to examination at day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2025
  2. Study start1 Aug 2025
  3. Primary completion30 Mar 2026 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
174 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07041164
Sponsor's protocol ID
MU-DT/PY-IRB 2025/025.0304
Acronym
NILT
Status last verified
Sep 2025
First submitted
19 Jun 2025
Last updated
29 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided: The individual participant data (IPD), as required by the ethical approval granted by MU-DT/PY-IRB, will remain confidential and will not be disclosed. All data will be reported in aggregate form in publications or reports, ensuring that no individual participant can be identified. Any disclosure beyond these conditions will require an amendment to the approved ethical protocol.

Questions about this trial

What is this clinical trial studying?

An observational study of Dental Caries (Diagnosis) and Diagnostic Imaging, run by Sawanya Prutthithaworn at 2 sites in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sawanya Prutthithaworn, Ph.D. (Dental biomaterials) (+6622007821 ext. 25, sawanya.pru@mahidol.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnosis performance (time frame: From enrollment to clinical examination on day 7th). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in